Jan'05 | Jan'06 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Jan'11 | Jan'12 | Dec'12 | Dec'13 | Dec'14 | Jan'16 | Jan'17 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $12.9B | $13.5B | $13.6B | $17.3B | $14.9B | $14.3B | $13.6B | $16.3B | $14.5B | $15.4B | $17.4B | $15.3B | $17.9B | $14.2B | $15.6B | $15.1B | $16.9B | $20.5B | $23.2B | $23.4B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Johnson & Johnson's last 12-month Operating Income is $22.1B, based on the financial report for Sep 29, 2024 (Q3 2024).
Over the last year, Johnson & Johnson's Operating Income growth was 2.9%. The average annual Operating Income growth rates for Johnson & Johnson have been 7.0% over the past three years, (0.2%) over the past five years.
Over the last year, Johnson & Johnson's Operating Income growth was 2.9%, which is higher than industry growth of 0.0%. It indicates that Johnson & Johnson's Operating Income growth is Good.